Discover Medpace’s Q3 2025 earnings: record bookings, rising backlog, and robust revenue/EBITDA growth outlook for 2026.
Q3 2025 Management View Chairman, President & CEO Robert Holmes highlighted the completion of the four-year transformation plan announced in 2021, reporting the firm achieved a 1.3% return on average ...
Q3 2025 Management View CEO Vincenzo Vena opened the call highlighting "our third quarter results serve as a proof point that we are successfully executing on our strategy. We are focused on driving ...